Evidence map›Paper›PMID 36311349›Full record

ArticleBio-protocol2022

Nilay Nandi, Charles Tracy, Helmut Krämer

Open access · greenAbstract read
In one paragraph

Article in Bio-protocol, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nilay NandiDepartment of Neuroscience, UT Southwestern Medical Center, Dallas, USA.
Charles TracyDepartment of Neuroscience, UT Southwestern Medical Center, Dallas, USA.
Helmut KrämerDepartment of Neuroscience, UT Southwestern Medical Center, Dallas, USA.
Southwestern Medical Center · US

Funding

MOLECULAR ANALYSIS OF THE BOSS TRANSMEMBRANE LIGANDR01EY010199 · NEI · UT SOUTHWESTERN MEDICAL CENTER · PI Helmut J Kramer · 1994 to 2026
$9.7M
Regulation of TLR signaling, Inflammation and Antigen Presentation by VPS33BR01AI155426 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI KRAMER, HELMUT J, PASARE, CHANDRASHEKHAR · 2021 to 2025
$3.4M
NEI NIH HHS R01 EY010199NIAID NIH HHS R01 AI155426
6 · The paper itself

Abstract

The activity of numerous autophagy-related proteins depends on their phosphorylation status, which places importance on understanding the responsible kinases and phosphatases. Great progress has been made in identifying kinases regulating autophagy, but much less is known about the phosphatases counteracting their function. Genetic screens and modern proteomic approaches provide powerful tools to identify candidate phosphatases, but further experiments are required to assign direct roles for candidates. We have devised a novel protocol to test the role of purified phosphatases in dephosphorylating specific targets

Indexed as

AcinusAutophagyCdk5DrosophilaMetal-dependent phosphatasesNilkanthaPhosphorylation

Identifiers

PMID36311349
PMCPMC9550347
OpenAlexW4296435767

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.